Danimer Scientific Inc.

OTC: DNMR · Real-Time Price · USD
0.35
0.00 (0.00%)
At close: Mar 18, 2025, 3:58 PM

Danimer Scientific Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-155.47M -179.76M -60.11M
Depreciation & Amortization
29.06M 20.09M 10.63M
Stock-Based Compensation
56.03M 56.96M 55.27M
Other Working Capital
3.89M -3.53M -10.29M
Other Non-Cash Items
9.81M 61.01M -26.65M
Deferred Income Tax
-199K -814K -13.23M
Change in Working Capital
13.5M -19.32M -28.87M
Operating Cash Flow
-47.26M -61.84M -62.96M
Capital Expenditures
-27.68M -164.49M -185.41M
Cash Acquisitions
n/a -14K -151.18M
Purchase of Investments
n/a -18.04M n/a
Sales Maturities Of Investments
n/a 18.04M n/a
Other Investing Acitivies
22K -17.98M 422K
Investing Cash Flow
-27.66M -182.48M -336.17M
Debt Repayment
83.67M 23.2M 213.08M
Common Stock Repurchased
n/a -236K -1.73M
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
506K -1.29M 94.85M
Financial Cash Flow
84.03M 21.75M 306.2M
Net Cash Flow
9.1M -222.57M -92.93M
Free Cash Flow
-74.95M -226.32M -248.37M